Drug and Therapeutics Bulletin 1997;35:73-74; doi:10.1136/dtb.1997.351073
Copyright © 1997 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

How Drug and Therapeutics Bulletin produces articles

Articles in Drug and Therapeutics Bulletin (DTB) aim to provide practical and impartial advice on treatment. Since it started in 1962, the way that DTB produces articles has been gradually refined but the essential principles remain unchanged. While each article starts as a draft commissioned by one of our editorial team and written by an expert, the finished article is the result of detailed scrutiny, collaboration and revision involving a wide range of commentators and several editing stages. The resulting article, no longer attributable to any one source, is published unsigned. Here we describe our approach to producing articles and discuss some of the difficulties they pose.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1997 BMJ Publishing Group Ltd.